MI
PROF

MMCAP International’s Profound Medical PROF Stock Holding History

MMCAP International’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.46M Sell
671,356
-73,796
-10% -$496K 0.38% 76
2026
Q1 		$4.83M Buy
745,152
+213,790
+40% +$1.48M 0.42% 71
2025
Q4 		$4.18M Buy
531,362
+30,503
+6% +$196K 0.42% 59
2025
Q3 		$2.45M Buy
500,859
+10,000
+2% +$51K 0.28% 66
2025
Q2 		$2.9M Buy
490,859
+10,000
+2% +$52.9K 0.35% 49
2025
Q1 		$2.8M Sell
480,859
-9,141
-2% -$63.1K 0.48% 36
2024
Q4 		$3.68M Buy
+490,000
New +$3.76M 0.55% 35

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
RMC
Ring Mountain Capital Tiburon, California $238M AUM 61.63% 1-Year Est. Return

MMCAP International's PROF Position: Q2 2026 in Review

MMCAP International reduced its Profound Medical (PROF) stake by 9.9% in Q2 2026, selling an estimated $496K and leaving 671,356 shares worth $4.46M. The position accounts for 0.38% of the portfolio, ranked #76.

MMCAP International first reported a position in PROF in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.83M in Q1 2026. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • MMCAP International held 671,356 shares of Profound Medical worth $4.46M as of Q2 2026.
  • MMCAP International sold 73,796 Profound Medical shares in Q2 2026, an estimated $496K.
  • Profound Medical made up 0.38% of MMCAP International's portfolio in Q2 2026, its #76 holding.
  • MMCAP International first reported a position in Profound Medical in Q4 2024 and has held it in 7 quarters since.
  • MMCAP International's Profound Medical position peaked at $4.83M in Q1 2026.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on MMCAP International's 13F filing for Q2 2026, filed 14 Aug 2026.